Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1
DNA methylation plays a pivotal role in the progression of renal fibrosis. Methyl-CpG–binding domain protein 2 (MBD2), a protein reader of methylation, is involved in the development of acute kidney injury (AKI) caused by vancomycin. However, the role and mechanism of action of MBD2 in renal remain...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-06-01
|
| Series: | Molecular Therapy: Nucleic Acids |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253122000439 |
| _version_ | 1819079104323911680 |
|---|---|
| author | Kai Ai Xiaozhou Li Pan Zhang Jian Pan Huiling Li Zhibiao He Hongliang Zhang Lei Yi Ye Kang Yinhuai Wang Junxiang Chen Yijian Li Xudong Xiang Xiangping Chai Dongshan Zhang |
| author_facet | Kai Ai Xiaozhou Li Pan Zhang Jian Pan Huiling Li Zhibiao He Hongliang Zhang Lei Yi Ye Kang Yinhuai Wang Junxiang Chen Yijian Li Xudong Xiang Xiangping Chai Dongshan Zhang |
| author_sort | Kai Ai |
| collection | DOAJ |
| description | DNA methylation plays a pivotal role in the progression of renal fibrosis. Methyl-CpG–binding domain protein 2 (MBD2), a protein reader of methylation, is involved in the development of acute kidney injury (AKI) caused by vancomycin. However, the role and mechanism of action of MBD2 in renal remain unclear. In this study, MBD2 mediated extracellular matrix (ECM) production induced by TGF-β1 in Boston University mouse proximal tubule (BUMPT) cells，and upregulated the expression EGR1 to promote ECM production in murine embryonic NIH 3T3 fibroblasts. ChIP analysis demonstrated that MBD2 physically interacted with the promoter region of the CpG islands of EGR1 genes and then activated their expression by inducing hypomethylation of the promoter region. In vivo, PT-MBD2-KO attenuated unilateral ureteral obstruction (UUO)-induced renal tubulointerstitial fibrosis via downregulation of EGR1, which was demonstrated by the downregulation of fibronectin (FN), collagen I and IV, α-SMA, and EGR1. Injection of MBD2-siRNA attenuated the UUO- and I/R-induced renal fibrosis. Those molecular changes were verified by biopsies from patients with obstructive nephropathy (OB). These data collectively demonstrated that inhibition of MBD2 reduces renal fibrosis via downregulating EGR1, which could be a target for treatment of fibrotic kidney disease. |
| first_indexed | 2024-12-21T19:23:41Z |
| format | Article |
| id | doaj.art-f0acc55d297c465897c4368f37998bbe |
| institution | Directory Open Access Journal |
| issn | 2162-2531 |
| language | English |
| last_indexed | 2024-12-21T19:23:41Z |
| publishDate | 2022-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Molecular Therapy: Nucleic Acids |
| spelling | doaj.art-f0acc55d297c465897c4368f37998bbe2022-12-21T18:52:53ZengElsevierMolecular Therapy: Nucleic Acids2162-25312022-06-01287786Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1Kai Ai0Xiaozhou Li1Pan Zhang2Jian Pan3Huiling Li4Zhibiao He5Hongliang Zhang6Lei Yi7Ye Kang8Yinhuai Wang9Junxiang Chen10Yijian Li11Xudong Xiang12Xiangping Chai13Dongshan Zhang14Department of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Emergency Medicine and Difficult Diseases Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Department of Urology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Emergency Medicine and Difficult Diseases Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Emergency Medicine and Difficult Diseases Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Emergency Medicine and Difficult Diseases Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Emergency Medicine and Difficult Diseases Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Emergency Medicine and Difficult Diseases Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Urology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Urology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Urology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Nephrology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Urology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Emergency Medicine and Difficult Diseases Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Emergency Medicine and Difficult Diseases Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of ChinaDepartment of Emergency Medicine, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Emergency Medicine and Difficult Diseases Institute, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China; Corresponding author Dongshan Zhang, Ph.D. Department of Emergency Medicine, Emergency Medicine and Difficult Diseases Institute, Department of Nephrology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, People's Republic of China.DNA methylation plays a pivotal role in the progression of renal fibrosis. Methyl-CpG–binding domain protein 2 (MBD2), a protein reader of methylation, is involved in the development of acute kidney injury (AKI) caused by vancomycin. However, the role and mechanism of action of MBD2 in renal remain unclear. In this study, MBD2 mediated extracellular matrix (ECM) production induced by TGF-β1 in Boston University mouse proximal tubule (BUMPT) cells，and upregulated the expression EGR1 to promote ECM production in murine embryonic NIH 3T3 fibroblasts. ChIP analysis demonstrated that MBD2 physically interacted with the promoter region of the CpG islands of EGR1 genes and then activated their expression by inducing hypomethylation of the promoter region. In vivo, PT-MBD2-KO attenuated unilateral ureteral obstruction (UUO)-induced renal tubulointerstitial fibrosis via downregulation of EGR1, which was demonstrated by the downregulation of fibronectin (FN), collagen I and IV, α-SMA, and EGR1. Injection of MBD2-siRNA attenuated the UUO- and I/R-induced renal fibrosis. Those molecular changes were verified by biopsies from patients with obstructive nephropathy (OB). These data collectively demonstrated that inhibition of MBD2 reduces renal fibrosis via downregulating EGR1, which could be a target for treatment of fibrotic kidney disease.http://www.sciencedirect.com/science/article/pii/S2162253122000439MT: BioinformaticsMBD2EGR1renal fibrosisUUOI/R |
| spellingShingle | Kai Ai Xiaozhou Li Pan Zhang Jian Pan Huiling Li Zhibiao He Hongliang Zhang Lei Yi Ye Kang Yinhuai Wang Junxiang Chen Yijian Li Xudong Xiang Xiangping Chai Dongshan Zhang Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1 Molecular Therapy: Nucleic Acids MT: Bioinformatics MBD2 EGR1 renal fibrosis UUO I/R |
| title | Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1 |
| title_full | Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1 |
| title_fullStr | Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1 |
| title_full_unstemmed | Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1 |
| title_short | Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1 |
| title_sort | genetic or sirna inhibition of mbd2 attenuates the uuo and i r induced renal fibrosis via downregulation of egr1 |
| topic | MT: Bioinformatics MBD2 EGR1 renal fibrosis UUO I/R |
| url | http://www.sciencedirect.com/science/article/pii/S2162253122000439 |
| work_keys_str_mv | AT kaiai geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT xiaozhouli geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT panzhang geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT jianpan geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT huilingli geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT zhibiaohe geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT hongliangzhang geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT leiyi geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT yekang geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT yinhuaiwang geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT junxiangchen geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT yijianli geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT xudongxiang geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT xiangpingchai geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 AT dongshanzhang geneticorsirnainhibitionofmbd2attenuatestheuuoandirinducedrenalfibrosisviadownregulationofegr1 |